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This study assessed the polyfunctional T cells in healthy household contacts (HHCs) and TB patients. This study also assessed the
memory subsets responsible for the secretion of IFN-𝗾 during the short-term culture with Mycobacterium tuberculosis antigens.
Frequencies of CD4
+IFN-𝗾
+TNF-𝗼
+ Tc e l l sa n dC D 8
+IFN-𝗾
+TNF-𝗼
+ T cells specific to M. tuberculosis antigens were significantly
higher in TB patients compared to HHC. IFN-𝗾-secreting T cells, during overnight stimulation with M. tuberculosis antigens,
belongedtoeffectormemorysubsetwithaCD45RA
−CD27
− phenotype.However,thenumberofIFN-𝗾-secretingeffectormemory
cells did not differ between HHC and TB patients.
1. Introduction
Tuberculosis (TB) is a global health problem with 2 billion
people infected with the causative agent Mycobacterium
tuberculosis (M. tuberculosis). Of these, only 10 percent will
progress to active TB disease resulting in almost 2 million
deaths per year [1]. This provides compelling evidence that
the human immune system is capable of controlling the
pathogen. However, the precise mechanisms contributing to
the loss of immune control and progression of active TB
disease are not known. A better understanding of these pro-
cessesiscriticalforthedevelopmentofimproveddiagnostics,
treatment protocols, and vaccines.
It has been long recognized that Interferon gamma (IFN-
𝗾) producing T cells provide the major effector response in
TB [2–5]. However, assessment of IFN-𝗾 producing T cells
alone may not be sufficient. Further analysis of various T
cell memory subsets, such as central memory and effector
memory subsets, may provide some light in understanding
the T cell protection in TB.
Tcellsareabletoproducemultiplefactorssimultaneously
and they are termed polyfunctional T cells. The evidence
from animal and human models of chronic viral infections
indicates that high levels of chronic antigen stimulation lead
tofunctionalimpairmentofantigen-specificTcellresponses,
with reduced cytokine production, cytotoxicity, and prolif-
erative capacity [6–11]. The capacity of antigen-specific T
cells to produce multiple cytokines simultaneously has been
associatedwithsuperiorfunctionalcapacity[12]andhasbeen
correlated with control of human chronic viral infections
such as human immunodeficiency virus (HIV) [13–15]a n d
hepatitis C virus (HCV) [16]. Moreover, polyfunctional T
c e l l sh a v eb e e na s s o c i a t e dw i t hp r o t e c t i o na g a i n s td i s e a s e
progression in mouse models of Leishmania major [17]a n d
M. tuberculosis [18]. Polyfunctional T cells, which produce
IFN-𝗾,IL-2,andTNF -𝗼,havebeendescribedinstudiesofM.
tuberculosis infected adults [19, 20], but they ended up with
contradicting results.
In this study, we have enumerated the polyfunctional T
cells in QuantiFERON-TB Gold in-tube (QFT-IT) positive
HHC and QFT-IT positive TB patients. We also looked
into the contribution of different memory T cell subset in
the secretion of IFN-𝗾 during short-term culture with TB
antigens.
2. Material and Methods
Th i ss t u d yp r o t o c o lw a sa p p r o v e db yt h eI n s t i t u t i o n a lE t h -
ical Committee of the National Institute of Research in2 ISRN Immunology
Tuberculosis (NIRT), India. NIRT was formerly known as
Tuberculosis Research Center. An informed written consent
wasobtainedfromstudysubjectsbeforethebloodwasdrawn.
2.1. Study Subjects. A total of 50 study subjects, who were
positive for QFT-IT, were selected for this study. Among
them, 25 were healthy household contacts (HHCs), and 25
subjectswerenewlydiagnosedactivepulmonaryTBpatients.
All the study subjects were recruited at the National Institute
for Research in Tuberculosis (NIRT), Chennai, India. Active
TB was confirmed by identification of M. tuberculosis by
c u l t u r ef r o ma tl e a s to n eo ft h e3s p u t u ms a m p l e s .N o n eo f
theTBpatientshadprevioushistoryofTB,andallwerena¨ ıve
fortheantituberculoustherapy.TheagerangeofTBwasfrom
28 to 52 years with a median of 36 years. Of them, 75%, were
males.
HHCs were identified from families, where there was at
least one case of sputum positive pulmonary TB living in the
samehousehold,foratleast3monthsimmediatelypreceding
thestartoftreatmentoftheindexcase.Amongthe25HHCs,
62% were males, and their age ranged from 25 to 55 years,
with a median of 32 years. All were na¨ ıve for TB prophylaxis
treatment.
2.2. Isolation of Peripheral Blood Mononuclear Cells (PBMCs).
PBMCs were isolated by density gradient centrifugation by
carefully layering heparinized blood over an equal volume of
Histopaque (Sigma-Aldrich Corp., St. Louis, MO, USA) and
spinning at 18
∘C for 30 minutes at 2000rpm. The buffy coat
containingperipheralbloodmononuclearcellswasremoved,
washed twice using Hanks’ balanced salt solution (HBSS)
(Sigma-AldrichCorp,St.Louis,MO,USA),andresuspended
in complete medium consisting of RPMI 1640 (Sigma-
Aldrich Corp., St. Louis, MO, USA), 2mM L-glutamine, 1%
100XAntibioticAntimycoticSolution(InvitrogenCorp.,CA,
USA), and 10% heat, inactivated human AB-serum (Sigma-
Aldrich Corp. MO, USA).
2.3. In Vitro Culture. PBMCs were stimulated overnight in
t h ep r e s e n c eo fP P D ,E S A T - 6 ,a n dC F P - 1 0p r o t e i n sa tt h e
concentration of 5𝜇g/mL or absence of any stimulant in a
37
∘C, 5% CO2 incubator. Just 4 hours prior to stopping the
reaction,5𝜇g/mLofBrefeldinAwasaddedtoeachwell.After
overnight incubation, the cells were washed with HBSS and
used for downstream process.
2.4. Intracellular Cytokine Assay. Cytokine-(IFN-𝗾,T N F - 𝗼
and IL-2) secreting T cells were enumerated by intracellular
cytokine staining method. Briefly, cells were washed and
labelledwithfluorochrome-conjugatedantibodiesforsurface
proteins. Then, the cells were fixed using Cytofix/Cytoperm
buffer (BD Biosciences, San Jose, CA, USA) and Washed
withPerm/washbuffer(BDBiosciences,SanJose,CA,USA).
The cells were then stained for intracellular cytokines. After
washing, cells were fixed using 1% paraformaldehyde. The
following combination of antibodies is used. To identify
multiple cytokine-secreting polyfunctional T cells, cells were
stained with CD4 PE-Cy5 or CD8 PE-Cy5, IL-2 APC, IFN-𝗾
Table1:Enumerationofantigen-specificIFN-𝗾,IL -2,a n dTNF -𝗼T
cells in HHC and TB patients.
Cytokine Antigen HHC
median (range)
TB
median (range)
𝑃 value
CD4 IFN-𝗾
PPD 0.30 (0–4.4) 0.9 (0–5.6) 0.137
ESAT-6 0.39 (0.09–3.4) 0.8 (0.1–3.8) 0.101
CFP-10 0.36 (0.1–6.7) 0.67 (0.13–2.4) 0.747
CD8 IFN-𝗾
PPD 0.35 (0.1–2) 0.52 (0–1.4) 0.901
ESAT-6 0.43 (0.04–1.9) 0.56 (0–1.8) 0.989
CFP-10 0.24 (0.1–1.1) 0.48 (0.06–2.0) 0.089
CD4 TNF-𝗼
PPD 0.37 (0.1–1.3) 0.57 (0–2.1) 0.036
ESAT-6 0.39 (0.2–2.4) 0.53 (0–2.1) 0.651
CFP-10 0.38 (0.1–6.7) 0.48 (0.1–5.9) 0.826
CD8 TNF-𝗼
PPD 0.54 (0.1–2.0) 0.62 (0–4.0) 0.505
ESAT-6 0.47 (0.16–3.1) 0.62 (0.18–5.1) 0.722
CFP-10 0.47 (0–2.8) 0.64 (0–3.1) 0.639
CD4 IL-2
PPD 0.47 (0.0–2.1) 0.58 (0–5.9) 0.181
ESAT-6 0.32 (0–4.1) 0.53 (0.1–1.9) 0.798
CFP-10 0.22 (0–4.6) 0.74 (0–2.3) 0.639
CD8 IL-2
PPD 0.55 (0.1–2.3) 0.38 (0–4.0) 0.730
ESAT-6 0.42 (0.1–2.7) 0.49 (0–4.9) 0.791
CFP-10 0.44 (0–2.2) 0.24 (0–3.2) 0.836
Alexa Fluor 488, and TNF-𝗼 PE. To identify the memory cell
subset, the cells were stained with CD4 APC or CD8 APC,
CD27 PE, CD45RA PE-Cy5, and IFN-𝗾 Alexa Fluor 488 (BD
Biosciences, San Jose, CA, USA).
2.5. Flow Cytometric Acquisition and Analysis. The sample
tubes containingparaformaldehyde-fixedcellswere acquired
usingaFACSCaliburFlowcytometerbuffer(BDBiosciences,
San Jose, CA, USA). The acquired flow cytometric data were
analyzed using FlowJo software (Tree Star Inc., San Carlos,
CA, USA) version 7.1.1.
2.6. Statistical Analysis. Statistical analysis was performed
using GraphPad Prism version 5.00 for Windows (GraphPad
Software, San Diego, CA, USA). Mann-Whitney “𝑈”t e s tw a s
carried out to calculate the differences between the groups.
Receiver operator curve (ROC) analysis was performed to
derive the cut-off points.
3. Results
3.1. Frequency of Single Cytokine-Secreting T Cells. Table 1
shows the number of PPD-, ESAT-6-, and CFP-10 specific
CD4
+IFN-𝗾
+ and CD8
+IFN-𝗾
+ Tc e l l su p o no v e r n i g h ts t i m -
ulation of PBMC from HHC and the TB patients. Although,
antigen-specific CD4
+IFN-𝗾
+ Tc e l l sw e r es l i g h t l yh i g h e r
in TB patients than HHC, the difference did not reach
statistical significance. Similarly, the frequency of antigen-
specific CD8
+IFN-𝗾
+ T cells also did not differ significantly
between HHC and TB.ISRN Immunology 3
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Figure 1: Enumeration of antigen-specific CD4
+IFN-𝗾
+TNF-𝗼
+ T cells in HHC and TB patients. Scatter plots show antigen-specific
CD4
+IFN-𝗾
+TNF-𝗼
+ T cells in HHC and TB patients. The frequency of antigen-specific ((a) PPD, (b) ESAT-6, and (c) CFP-10) CD4
+IFN-
𝗾
+TNF-𝗼
+ T cells was significantly higher in TB patients compared to HHC for all three antigens. The difference between HHC and TB was
calculated by Mann-Whitney 𝑈 test. TB: tuberculosis patients; HHCs: healthy household contacts.
While the proportion of PPD specific CD4
+TNF-𝗼
+ T
cells was significantly higher in TB patients (median, 0.37%)
compared to HHC (median, 0.57%) (𝑃 = 0.036), ESAT-6 or
CFP-10 specific CD4
+TNF-𝗼
+ T cells did not differ between
thosetwogroups.TheproportionofantigenspecificCD4
+IL-
2
+ or CD8
+IL-2
+ cells did not differ between HHC and TB
patients (Table 1).
3.2. Frequency of Polyfunctional T Cells. There was an
increase in the expression of IFN-𝗾
+IL-2
+ and IFN-𝗾
+ TNF-
𝗼
+ (dual cytokine secreting) T cells, when PBMC from HHC
and TB patients were stimulated with antigens for overnight.
Interestingly, significantly higher frequency of CD4
+ IFN-
𝗾
+TNF-𝗼
+ Tc e l l sa n dC D 8
+ IFN-𝗾
+TNF-𝗼
+ Tc e l l sw a s
observed in TB patients compared to HHC for all the three
antigens (PPD, ESAT-6, and CFP-10) used in our study
(Figures 1 and 2). Another subset CD4
+IFN-𝗾
+IL-2
+ Tc e l l s
orCD8
+IFN-𝗾
+IL-2
+ TcellsdidnotdifferbetweenHHCand
TB patients (Figure 3).
The quantitative increase of IFN-𝗾
+TNF-𝗼
+ Tc e l l si n
TB patients compared to HHC prompted us to calculate the
sensitivity and specificity, when the numbers of IFN-𝗾
+TNF-
𝗼
+ T cells were enumerated to differentiate HHC and TB
patients. We derived cut-off points for each antigen specific
of IFN-𝗾
+TNF-𝗼
+ Tc e l ls u b s e tu s i n gH H Ca sc o n t r o l sa n d
TB patients as diseased.
With a cut-off value 0.255 (AUC, 0.672: 95% confidence
interval (CI), 0.521–0.832) for PPD-specific CD4
+ IFN-
𝗾
+TNF-𝗼
+ Tc e l l s ,1 2o u to f2 5T Bp a t i e n t sa n d1o u to f2 5
HHCs were found to be positive. This yielded a sensitivity of
48% (95% CI, 27.8%–68.7%) with a specificity of 96% (95%
CI, 74.7%–99.9%) (Table 2). The cut-off values 0.225 (AUC,
0.626: 95% CI, 0.456–0.795) and 0.310 (AUC, 0.743:95% CI,
0.582–0.905) were derived for ESAT-6 and CFP-10 specific
of CD4
+IFN-𝗾
+TNF-𝗼
+ T cells, respectively. ESAT-6- and
CFP-10-specific CD4
+IFN-𝗾
+TNF-𝗼
+ Tc e l l ss h o w e ds e n s i -
tivities of 48% (95% CI, 27.8%–68.7%) and 52% (95% CI,
31.3%–72.2%) with specificities of 100% and 96% (95% CI,4 ISRN Immunology
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Figure 2: Enumeration of antigen-specific CD8
+IFN-𝗾
+TNF-𝗼
+ T cells in HHC and TB patients. Scatter plots show antigen-specific
CD8
+IFN-𝗾
+TNF-𝗼
+ T cells in HHC and TB patients. The frequency of antigen ((a) PPD, (b) ESAT-6, and (c) CFP-10) CD8
+IFN-𝗾
+TNF-𝗼
+
T cells was significantly higher in TB patients compared to HHC for all three antigens. The difference between HHC and TB was calculated
by Mann-Whitney 𝑈 test. T: tuberculosis patients; HHCs: healthy household contacts.
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Figure 3: Enumeration of antigen-specific dual cytokine-secreting T cells in HHC and TB patients. Box and Whisker plots show range,
interquartile range, and median of antigen-specific CD4
+IFN-𝗾
+IL-2
+ Tc e l l( a )a n dC D 8
+IFN-𝗾
+IL-2
+ T cell (b) in HHC and TB patients.
ThefrequencyofIFN-𝗾
+IL-2
+ TcellsubsetdidnotdifferbetweenHHCandTBpatients.ThedifferencebetweenHHCandTBwascalculated
by Mann-Whitney 𝑈 test. TB: tuberculosis patients; HHCs: healthy household contacts.ISRN Immunology 5
4
3
2
1
0
Contact TB Contact TB Contact TB
EM CM TM
I
F
N
-
𝗾
-
s
e
c
r
e
t
i
n
g
 
T
 
c
e
l
l
s
 
(
%
)
(a)
3
2
1
0
Contact TB Contact TB Contact TB
EM CM TM
I
F
N
-
𝗾
-
s
e
c
r
e
t
i
n
g
 
T
 
c
e
l
l
s
 
(
%
)
(b)
5
4
3
2
1
0
Contact TB Contact TB Contact TB
EM CM TM
I
F
N
-
𝗾
-
s
e
c
r
e
t
i
n
g
 
T
 
c
e
l
l
s
 
(
%
)
(c)
Figure 4: Memory phenotype of antigen-specific CD4
+IFN-𝗾
+ T cells in HHC and TB patients. Box and Whisker plots show range, inter-
quartile range, and median of antigen-specific IFN-𝗾-secreting memory T cell subsets in HHC and TB patients. Effector memory subset
secretes more IFN-𝗾 than other memory subsets in HHC and TB patients. The difference between HHC and TB was calculated by Mann-
Whitneytest.EM-EffectormemoryTcell;CM:CentralMemoryTcell;TM:terminallydifferentiatedmemoryTcell;TB:tuberculosispatients;
HHCs: healthy household contacts.
74.7%–99.9%), respectively, for differentiating TB patients
a n dH H C .W h e nt h er e s u l t so fE S A T - 6a n dC F P - 1 0w e r e
combined, it showed a sensitivity of 68% with a specificity of
96%.
Similarly,PPD-,ESAT-6-,andCFP-10-specificCD8
+IFN-
𝗾
+TNF-𝗼
+ T cells showed sensitivities of 36%, 20%, and
32% and specificities of 96% for diagnosing TB patients. The
combination of ESAT-6 and CFP-10 results did not improve
the sensitivity (Table 2).
3.3. Memory T Cell Subtypes. Based on the expression of
CD27 and CD45RA, memory subsets can be classified
as central memory (CD27
+CD45RA
−), effector memory
(CD27
−CD45RA
−), and terminally differentiated memory
(CD27
−CD45RA
+) subsets (49). Frequency of IFN-𝗾
+ Tc e ll s
in all the CD4 and CD8 memory subsets were enumerated
(Figures 4 and 5).
Upon overnight stimulation with antigens (PPD, ESAT-
6, and CFP-10), effector memory subset expressed a sig-
nificantly higher level of IFN-𝗾, compared to terminally
differentiatedmemoryandcentralmemorysubset.However,
thefrequencyoftheIFN-𝗾-secretingTcellsfromanyofthese
T cell subsets did not differ significantly between HHC and
TB patients.
4. Discussion
This study enumerated the number of polyfunctional T
cells in QFT-IT positive HHC and TB patients. In addition,
this study also assessed the memory subsets, which were
responsible for the secretion of IFN-𝗾 in QFT-IT positive
HHC and TB patients during the short-term culture with
M. tuberculosis a n t i g e n s .W eu s e dE S A T - 6a n dC F P - 1 0a n t i -
gens to identify M. tuberculosis-specific T cells, since these
antigens are used in commercial QFT-IT assays. In addition,
we also used PPD as it is suggested that it induces IFN-𝗾
s e c r e t i o ni nH H C ,a sw e l la si nT Bp a t i e n t s .
W ef o u n dt h a tt h en u m b e r so fI F N - 𝗾
+TNF-𝗼
+ Tc e l l s
were significantly higher in TB patients compared to HHC.
This is the first study which compared the IFN-𝗾
+TNF-𝗼
+6 ISRN Immunology
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Figure 5: Memory phenotype of antigen-specific CD8
+IFN-𝗾
+ T cells in HHC and TB patients. Box and Whisker plots show range, inter-
quartile range, and median of antigen-specific IFN-𝗾-secreting memory T cell subsets in HHC and TB patients. Effector memory subset
secretes more IFN-𝗾 than other memory subsets in HHC and TB patients. The difference between HHC and TB was calculated by Mann-
Whitneytest.EM:effectormemoryTcell;CM:centralMemoryTcell;TM:terminallydifferentiatedmemoryTcell;TB:tuberculosispatients;
HHCs: healthy household contacts.
T a b l e2 :S e n s i t i v i t ya n ds p e c i fi c i t yf o rC D 4
+IFN-𝗾
+TNF-𝗼
+ and CD8
+IFN-𝗾
+TNF-𝗼
+ T cells in discriminating HHC and TB patients.
Phenotype Antigen Cut-off value % Sensitivity (95% CI) % Specificity (95% CI)
CD4
PPD 0.27 48 (27.8–68.7) 96 (79.7–99.9)
ESAT-6 0.23 48 (27.8–68.7) 100
CFP-10 0.31 52 (31.3–72.2) 96 (74.7–99.9)
ESAT-6 + CFP-10 68 (49.7–86.3) 96 (79.7–99.9)
CD8
PPD 0.27 36 (18.0–57.5) 96 (79.7–99.9)
ESAT-6 0.24 20 (6.8–40.7) 96 (79.7–99.9)
CFP-10 0.20 32 (15–53.5) 96 (79.7–99.9)
ESAT-6 + CFP-10 32 (15–53.5) 96 (79.7–99.9)
T cells between HHC and TB patients. An earlier study,
which was conductedin HIV positivelatent TB subjects, also
reported higher frequency of IFN-𝗾
+TNF-𝗼
+ CD4 cells [20].
However, this study did not compare the number of IFN-
𝗾
+TNF-𝗼
+ T cells between latent and active TB patients.
Youngetal.alsocomparedthenumberofsinglecytokine-
secreting T cells and polyfunctional T cells in TB patients
before and after chemotherapy and found that the number
of polyfunctional T cells was decreased after successful TB
therapy [21]. During the chronic infection with M. tubercu-
losis, the host slowly loses the important characteristics of
t h ei m m u n ec e l l ss u c ha sc y t o k i n es e c r e t i o na n dc y t o l y t i c
property [22]. We speculate that the exhaustion of T cells in
theTBinfectedindividualsendowsTcellswithpolyfunctionsISRN Immunology 7
such as the secretion of more than a single cytokine. This
might be the reason for the higher number of IFN-𝗾
+TNF-
𝗼
+ polyfunctional T cells in TB patients compared to HHC
in our study. Due to the small number of study subjects in
eachgroup,wecouldnotfindanyassociationbetweenclinical
outcome and changes in the number of polyfunctional T
cells. Therefore, further studies are needed to confirm the
roleofpolyfunctionalTcellsinprotectivemechanismagainst
TB.
On the other hand, we found that the number of single
(either IFN-𝗾 or TNF-𝗼) cytokine-secreting T cells did not
differ between these two groups, except the PPD-specific
TNF-𝗼. This study results corroborates with our earlier
observations [23, 24]. PPD-specific TNF-𝗼 was significantly
higher in TB patients compared to HHC. The recent study
conducted by Harari et al. also found that TB patients were
found to have higher frequency of antigen-pecific TNF-
𝗼 compared to subjects with latent TB [25]. However, the
numberofESAT-6-andCFP-10-specificTNF-𝗼didnotdiffer
between TB patients and HHC in our study.
When we analyzed the sensitivity and specificity of
antigen-specific CD4
+IFN-𝗾
+TNF-𝗼
+, in differentiating
HHC and TB patients, the combination of ESAT-6 and
CFP-10 CD4
+IFN-𝗾
+TNF-𝗼
+ showed a moderate sensitivity
of 68% with a specificity of 96%. CD8
+IFN-𝗾
+ TNF-𝗼
+ T
cells could produce only 36% of sensitivity with a specificity
of 96%. There was no difference in demographic details or
clinical and bacteriological features between the TB patients
which were dual cytokine positive and those who were
negative. Therefore, further studies with larger number of
study subjects are needed to answer why few of the TB
patients in this study had low number of IFN-𝗾
+TNF-𝗼
+
T cells, similar to HHC. Further studies have to also test
the sensitivity of IFN-𝗾
+ TNF-𝗼
+ Tc e l l si ns m e a rn e g a t i v e ,
clinically diagnosed TB cases, where confirmation of TB
is difficult. Furthermore, the cut-off points calculated in
the study for CD4
+IFN-𝗾
+ TNF-𝗼
+ T cells also have to be
reconfirmed with large number of study subjects.
The profile of IFN-𝗾
+IL-2
+ Tc e l l sw a ss t u d i e di nv a r i o u s
viralinfectionsandTBpatients[26–31].Inmanyoftheearlier
studies, IFN-𝗾
+IL-2
+ Tc e l l sw e r es u g g e s t e da sp o s i t i v ec o r -
relates to the protection. Antigen clearance of past influenza
infection was correlated with CD4 T cells secreting IFN-
𝗾
+IL-2
+ [27]. While high viral load in cytomegalovirus was
associated with high number of IFN-𝗾 alone positive T cells,
the subjects with low viral load had high number of IFN-
𝗾
+IL-2
+ dual cytokine-secreting T cells [28]. Similar trend
was observed for other viral infections such as hepatitis C
virus, HSV, Epstein-Barr Virus, and HIV [29–31]. The TB
patients, who have completed successful anti TB treatment,
were found to have higher frequency of IFN-𝗾
+IL-2
+ or IFN-
𝗾
+IL-2
+TNF-𝗼
+Tc e l l s[ 32, 33].
Based on the above observations, we expected that
number of IFN-𝗾
+IL-2
+ Tc e l l sw o u l db eh i g h e ri nH H C
compared to TB patients. However, this trend was not found
in our study. There was less number of IFN-𝗾
+IL-2
+ Tc e l l s ,
similartoTB,inHHC.Anearlierstudyconductedinsubjects
with latent TB and HIV-1 infection also reported a fewer
number of IFN-𝗾
+IL-2
+ Tc e l l s[ 20].
B a s e do nt h ee x p r e s s i o no fp h e n o t y p i cm a r k e r sC D 4 5 R A
and CD27, the antigenic memory cells are classified as
effector memory T cells, central memory T cells, terminally
differentiated T memory cells, and na¨ ıve cells. The present
study results indicate that the effector memory T cells secrete
IFN-𝗾 in response to M. tuberculosis-specific antigens during
t h es h o r t - t e r mi n c u b a t i o n .Th i ss t u d yr e s u l t sc o r r o b o r a t e
with the earlier study results conducted by Goletti et al. [34].
But some of the antigen specific cells were having CD45RA
+
and CD27
− phenotype. This indicates that the terminally
differentiated effector T cells also secrete IFN-𝗾,t os o m e
extent, in response to M. tuberculosis antigens during the
short-term incubation. However, number and phenotype of
IFN-𝗾-secreting T cell were similar in HHC and TB patients.
Altogether, this study concludes that TB patients were
found to have higher number of IFN-𝗾
+TNF-𝗼
+ Tc e l l s ,
compared to HHC. The effector memory subset, with a
phenotypeofCD45RA-CD27-Tcells,playsanimportantrole
in the secretion of IFN-𝗾 compared to other subsets during
s h o r tt e r mi n c u b a t i o nw i t hT Ba n t i g e n s .
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